The company is aiming to produce at least 2 billion doses of its vaccine in 2022, of which the U.S. has ordered 100 million.
Related posts:
Biden rolls back Trump’s anti-abortion curbs on family planning funds
Biden administration investing $1.7B to better track Covid-19 variants
U.S. pledges medical aid for India to combat surge
Fauci: Pandemic exposed ‘undeniable effects of racism’
CDC remakes its Covid-19 response after criticism over mask guidelines
Democrats back growing calls for Congress to probe lab leak theory
NIH director sees ‘no signs’ of a Delta peak
Biden administration to encourage boosters for most Americans
Gov. Greg Abbott bans Covid vaccine mandates in Texas, regardless of FDA approval status
Sinema tells White House she’s opposed to current prescription drug plan
CDC recommends waiting period for Afghan flights to U.S. after measles cases
Fauci: ‘I don’t think people should expect’ a domestic flight vaccine mandate
